Rebalix
Logo InvescoInvesco · sheet of 5 September 2026
ETF sheet · official issuer and register data

Invesco S&P China A MidCap 500 Swap UCITS ETF Acc

C500 · IE0000FCGYF9 · class Acc · USD · domicile Ireland
Equity · China · Mid capSFDR art. 6
Index tracked: S&P China A MidCap 500 Index
TER
0.35%+ trans. 0.00%
Fund size
39 m EUR
Tracking difference
not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Synthetic (swap)
Income
Accumulating
Launch 5 May 2022 · costs from the KID as of 14 Aug 2026 · 107 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 2 Sept 2026
Redemption and Dealing of Shares: The Fund's shares are listed on one or more Stock Exchange(s). Investors can buy or sell shares daily through an intermediary directly or on Stock Exchange(s) on which the shares are traded. In exceptional circumstances investors will be permitted to redeem their shares directly from the Umbrella Fund in accordance with the redemption procedures set out in the prospectus, subject to any applicable laws and relevant charges. Investment objective: The objective of the Fund is to achieve the net total return performance of…

Performance since series start (in euro) — base 100

5 May 202213 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
202320242025202619677174
High 196 (1 Jul 2026) · low 77 (5 Feb 2024) · last 174. Past performance is not indicative of future results.

Returns in euro

1 year+45.0%
3 years+78.6%
5 yearsseries too young
10 yearsseries too young
Since series start+74.4%

Risk · 1 / 3 / 5 years

Volatility (ann.)26.39%25.63%
Max drawdown−17.76%−21.65%
Sharpe1.160.88
Sortino1.671.32
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · C500 · IE0000FCGYF91
RebalixC500 · IE0000FCGYF9 · sheet of 5 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years
Not honestly computable: under review: anomalies in the fund or index series

Holdings

Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 31 Aug 2026 · 107 securities · top-10 weight = 32.8%
Top holdingsWeight
AMAZON.COM INC4.9%
UBS GROUP AG-REG4.9%
MICRON TECHNOLOGY INC4.1%
APPLE INC3.7%
ABB LTD-REG3.2%
NVIDIA CORP2.9%
ZURICH INSURANCE GROUP AG2.3%
NESTLE SA-REG2.3%
DSV A/S2.2%
CIE FINANCIERE RICHEMO-A REG2.2%

Listing venues

ESMA register (FIRDS) and official exchange lists
C500 · Borsa Italiana (ETFplus)
C5ME · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 6 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Factsheet · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Prospectus · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/umbr
The live sheet, always up to date
rebalix.com/en/etf/IE0000FCGYF9
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · C500 · IE0000FCGYF92